As a contribution towards its 2015 Sustainability Goals, the Dow Chemical Company aims to improve the efficiency of the pharmaceutical manufacturing process and thus ultimately help improve the human health. A new technology from Dow Wolff Cellulosics, METHOCELTM Premium Cellulose Ethers for Direct Compression, allows pharmaceutical companies to produce tablets in fewer steps – reducing the cost of manufacturing. Using a product based on abundant and renewable resources, METHOCELTM for Direct Compression is an example of innovation in the formulation of oral solid dose medications designed to treat diseases and medical conditions… read more
Dow new technology reduces time and cost to manufacture pharmaceutical tablets
As a contribution towards its 2015 Sustainability Goals, the Dow Chemical Company aims to improve the efficiency of the pharmaceutical manufacturing process and thus ultimately help improve the human health. A new technology from Dow Wolff Cellulosics, METHOCELTM Premium Cellulose Ethers for Direct Compression, allows pharmaceutical companies to produce tablets in fewer steps – reducing the cost of manufacturing. Using a product based on abundant and renewable resources, METHOCELTM for Direct Compression is an example of innovation in the formulation of oral solid dose medications designed to treat diseases and medical conditions… read more